Combination of methotrexate and sulfasalazine is an efficacious option for axial spondyloarthritis in a resource-limited, real-world clinical setting: a prospective cohort study-Reference-Cited by-同舟云学术

Combination of methotrexate and sulfasalazine is an efficacious option for axial spondyloarthritis in a resource-limited, real-world clinical setting: a prospective cohort study

Published:2020-10-14 Issue:5 Volume:40 Page:1871-1879
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Ganapati Arvind,Gowri Mahasampath,Antonisamy Belavendra,Danda Debashish^ORCID

Funder

Christian Medical College, Vellore

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-020-05433-5.pdf

Reference33 articles.

1. Möttönen T, Hannonen P, Leirisalo-Repo M, Nissilä M, Kautiainen H, Korpela M, Laasonen L, Julkunen H, Luukkainen R, Vuori K, Paimela L, Blåfield H, Hakala M, Ilva K, Yli-Kerttula U, Puolakka K, Järvinen P, Hakola M, Piirainen H, Ahonen J, Pälvimäki I, Forsberg S, Koota K, Friman C (1999) Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet Lond Engl 353:1568–1573. https://doi.org/10.1016/s0140-6736(98)08513-4

2. Boers M, Verhoeven AC, Markusse HM, van de Laar MAFJ, Westhovens R, van Denderen JC, van Zeben D, Dijkmans BAC, Peeters AJ, Jacobs P, van den Brink HR, Schouten HJA, van der Heijde DMFM, Boonen A, van der Linden S (1997) Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet Lond Engl 350:309–318. https://doi.org/10.1016/S0140-6736(97)01300-7

3. Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R, Collantes-Estevez E, Dagfinrud H, Dijkmans B, Dougados M, Emery P, Geher P, Hammoudeh M, Inman RD, Jongkees M, Khan MA, Kiltz U, Kvien TK, Leirisalo-Repo M, Maksymowych WP, Olivieri I, Pavelka K, Sieper J, Stanislawska-Biernat E, Wendling D, Özgocmen S, van Drogen C, van Royen B, van der Heijde D (2011) 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 70:896–904. https://doi.org/10.1136/ard.2011.151027

4. Dougados M, vam der Linden S, Leirisalo-Repo M et al (1995) Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum 38:618–627. https://doi.org/10.1002/art.1780380507

5. Clegg DO, Reda DJ, Abdellatif M (1999) Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study. Arthritis Rheum 42:2325–2329. https://doi.org/10.1002/1529-0131(199911)42:11<2325::AID-ANR10>3.0.CO;2-C

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Effectiveness of Tofacitinib and Adalimumab in Axial Spondyloarthritis;JCR: Journal of Clinical Rheumatology;2024-03-21

2. Combination of methotrexate with oral disease-modifying antirheumatic drugs in psoriatic arthritis: a systematic review;Immunotherapy;2024-02

3. Do Tofacitinib Generics Exhibit Conventional Synthetic Disease-Modifying Anti-rheumatic Drug and Non-steroidal Anti-inflammatory Drug-Sparing Ability in the Management of Axial Spondyloarthritis?;Cureus;2023-10-02

4. Real-World Retention and Clinical Effectiveness of Secukinumab for Axial Spondyloarthritis: Results From the Canadian Spondyloarthritis Research Network;The Journal of Rheumatology;2023-01-15

5. Emerging story of gut dysbiosis in spondyloarthropathy: From gastrointestinal inflammation to spondyloarthritis;Frontiers in Cellular and Infection Microbiology;2022-08-22